全球医药中间体市场-市场规模、份额和增长分析：按产品（化学中间体、API中间体）、按应用（镇痛药、抗炎药）-行业预测（2023-2030）

2021年全球医药中间体市场规模将达到290亿美元，2022年将达到306亿美元。 预计该市场在预测期内（2023-2030年）将以復合年增长率6.3%的速度扩张，并于2030年扩大至526亿美元。

医药中间体作为原料药的生产原料发挥着重要作用。 这些中间体是在进一步加工之前的活性药物成分 (API) 合成过程中形成的。 这些中间体均采用优质基础原料製成，广泛应用于医药和化妆品行业。 由于这些领域的需求不断增长，特别是用于研发目的，全球医药中间体市场正在经历增长。

慢性病患病率的上升和世界人口的老龄化是导致对治疗这些疾病的药物製剂的需求增加的重要因素。 根据世界卫生组织（WHO）的数据，糖尿病患者人数从1980年的1.08亿增加到2014年的4.22亿，并且这一趋势仍在持续。 此外，世界卫生组织预测，到 2020 年，慢性病的发病率将增加 57%，这意味着很大一部分人口受到这些疾病的影响。 因此，由于这些驱动因素，医药市场在预测期内呈现增长。

全球医药中间体市场面临两个关键因素驱动的增长挑战。 首先，获得生物药品的高成本是一个主要障碍。 其次，生产活性药物成分（API）所需的高资本投资是限制市场增长的重要因素。

本报告考察了全球医药中间体市场，并按产品、应用、地区和进入市场的公司概况提供了市场概述以及趋势。

内容

执行摘要

调查方法

母公司市场分析

• 市场概况
• 市场规模
• 市场动态

主要市场洞察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 知识产权分析
• 贸易分析
• 启动分析
• 原材料分析
• 创新矩阵
• 管道产品分析
• 宏观经济指标
• 热门投资分析
• 关键成功因素
• 争用程度

市场动态与展望

• 市场动态
  • 驱动程序
  • 机会
  • 制约因素
  • 任务
• 监管状况
• 波特分析

全球医药中间体市场，按产品

• 市场概况
• 化学中间体
• API中间体
• 和定制中间体

全球医药中间体市场，按应用划分

• 市场概况
• 止痛药
• 抗炎药
• 心血管药物
• 抗糖尿病药物
• 抗癌剂

全球医药中间体市场规模（按地区）

• 市场概况
• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲

竞争格局

主要公司简介

• BASF SE
• Lonza Group AG
• Thermo Fisher Scientific Inc.
• Wuxi AppTec Co. Ltd.
• Merck KGaA
• Dishman Group
• Codexis Inc.
• Cambrex Corporation
• Hikal Ltd.
• Chemcon Speciality Chemicals Ltd.
• Porton Fine Chemicals Ltd.
• Divis Laboratories Ltd.
• Pfizer CentreOne
• Aurobindo Pharma Ltd.
• Sanofi SA
• Lianhe Chemical Technology Co. Ltd.
• Jiangsu Hengrui Medicine Co. Ltd.
• Shandong Xinhua Pharmaceutical Co. Ltd.
• WuXi STA
• Zhejiang NHU Co. Ltd.

Global Pharmaceutical Intermediates Market size was valued at USD 29 billion in 2021 and is poised to grow from USD 30.6 billion in 2022 to USD 52.6 billion by 2030, growing at a CAGR of 6.3% in the forecast period (2023-2030).

Pharmaceutical intermediates play a crucial role as raw materials in the production of bulk drugs. These intermediates are formed during the synthesis of active pharmaceutical ingredients (APIs) before further processing. They are derived from high-quality basic ingredients and find extensive applications in the pharmaceutical and cosmetic industries. The global market for pharmaceutical intermediates is experiencing growth due to the rising demand in these sectors, particularly for research and development purposes.

These intermediates are essential in the manufacturing of various products, including pesticides, drugs, resins, additives, plasticizers, and more, using materials like coal tar or petroleum. The market's expansion is primarily driven by the increased production of active pharmaceutical ingredients, responding to the growing demand for advanced therapies with improved delivery systems and personalized medicines worldwide.

Despite the positive outlook, the industry faces challenges such as the high cost of acquiring biopharmaceutical drugs and substantial apital investments required for API production. However, the introduction of new technologies in pharmaceutical manufacturing and increased investment in research activities are expected to create promising growth opportunities in the coming years.

Segments covered in this report:

Global pharmaceutical intermediates market is segmented on the basis of product, application, and region. On the basis of product, global market is segmented into chemical intermediates, bulk drug intermediates and custom intermediates. On the basis of application, global market is segmented into, analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs and anti-cancer drugs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The rising prevalence of chronic diseases and the global aging population are significant factors contributing to an increased demand for drug formulations to manage these conditions. According to the World Health Organization (WHO), the cases of diabetes have escalated from 108.0 million in 1980 to 422.0 million in 2014, with a continuous upward trend. Additionally, the WHO predicts a 57% increase in the incidence of chronic diseases by 2020, signifying a substantial portion of the population being affected by these conditions. As a result, the pharmaceutical market is witnessing growth during the forecast period due to these driving factors.

Restraint

The global pharmaceutical intermediates market faces challenges to its growth due to two significant factors. Firstly, the high expenses associated with acquiring biopharmaceutical drugs act as a major hindrance. Secondly, the substantial capital investment required for the production of active pharmaceutical ingredients (APIs) serves as a significant restraint that could impede the market's growth.

Market Trends

The cost incurred by the nation's healthcare system due to heart disease is on the rise. An important trend observed in the pharmaceutical intermediates market is the increasing prevalence of chronic cardiovascular conditions like heart failure and coronary artery disease. A July 2020 paper published in the Curious Journal of Medical Science states that ischemic heart disease (IHD) ranks as the leading cause of death worldwide. Approximately 126 million people globally are affected by ischemic heart disease. The projections indicate that by 2030, there will be over 1,845 cases of ischemic heart disease per 100,000 individuals worldwide.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Pharmaceutical Intermediates Market by Product

• Market Overview
• Chemical intermediates
• Bulk drug intermediates
• and Custom intermediates

Global Pharmaceutical Intermediates Market by Application

• Market Overview
• Analgesics
• Anti-inflammatory drug
• Cardiovascular drugs
• Anti-diabetic drugs
• Anti-cancer drugs

Global Pharmaceutical Intermediates Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi AppTec Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dishman Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikal Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemcon Speciality Chemicals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Porton Fine Chemicals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divis Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer CentreOne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lianhe Chemical Technology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Hengrui Medicine Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Xinhua Pharmaceutical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi STA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang NHU Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments